BioResearch
Aveo Enters Agreement with Schering-Plough to License, Develop Cancer Drugs
Aveo Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel cancer medicines, has entered into an exclusive worldwide agreement with Schering-Plough Corporation to develop and commercialize AV-299. More...19 Apr 2007
In Other News
MicroBeam Laser Microdissection System Developed for Live-Cell Applications
Protein Has Key Role in Muscle Cell Fusion
Biotech Companies Fight Aging at the Cellular Level
Targeting Tumors Nature's Way
Blueberry Compound May Help Prevent Colon Cancer
Engineered Endonucleases Could Become Major Gene Therapy Tools
Activation of the p53 Pathway Defeats Aggressive Viral Lymphoma
Fiberoptic Probe Visualizes Early Cancers
Market for Diabetes Diagnostics and Therapeutics is Escalating
Immuno-Capture Technology Optimized for Mass Spectrometer Detection
Leica Microsystems Signs Distribution Agreement with French Company
Tissue Engineering for Craniofacial Reconstruction
Inhibition of Transglutaminase Triggers Death of Pancreatic Cancer Cells
Preventing Cancer without Harming Cells
Green Tea Shows Potential in HIV Adjunctive Therapies
Possible Therapeutic Use for a Cardiac RNA Fragment
Collaboration Promotes Use of Protein Arrays in Search for Kinase Inhibitors
Meridian Bioscience Restructures and Expands Life Sciences
Safe Effective Therapy Treats Paroxysmal Nocturnal Hemoglobinuria
Pain Therapeutics Licenses Biotechnology to Treat Hemophilia
AstraZeneca Inaugurates US$15 Million Facility in India
Leukemic Cells Escape Cancer Drug in Bone Marrow
MilleGen and LFB Sign Research Partnership Agreement
BioResearch brings the latest research news on the genome, proteome, metabolome, on drug discovery, and therapeutics. Biotech researchers, lab administrators, technologists, drug manufacturers, and suppliers can find the latest research news and information related to their fields of endeavor here.







